An Intelligent Classification Diagnosis Based on Blood Oxygen Saturation Signals for Medical Data Security Including COVID-19 in Industry 5.0

Obstructive sleep apnea-hypopnea syndrome (OSAHS) is gradually valued due to its high prevalence, high risk, and high mortality. Alternative to the polysomnography (PSG) diagnosis, the proposed method assesses the subject's degree of illness considering the supply chain and Industry 5.0 requirement efficiently and accurately. This article uses the blood oxygen saturation (SpO(2)) signal count of the number of apnea or hypoventilation events during the sleep of the subject, calculating the apnea-hypopnea index (AHI) and the subject's disease level. SpO(2) signals are used to extract 35-D features based on the time domain, including approximate entropy, central tendency measure, and Lempel-Ziv complexity to accelerate the diagnosis process in supply chains. The feature selection process is reduced from 35 to 7 dimensions that benefits to the implementation in the practical supply chains in Industry 5.0 by extracting the extracted features. This article applies Pearson correlation coefficient selection, based on minimum redundancy-maximum correlation algorithm selection, and a wrapper based on the backward search algorithm. The accuracy rate is 86.92%, and the specificity is 90.7% under the selected random forest classifier. A random forest classifier was used to calculate the AHI index, and a linear regression analysis was performed with the AHI index obtained from the PSG. The result reaches a 92% accuracy rate in assessing the prevalence of OSAHS, satisfying the industrial deployment.

Residual Learning Diagnosis Detection: An Advanced Residual Learning Diagnosis Detection System for COVID-19 in Industrial Internet of Things

Due to the fast transmission speed and severe health damage, COVID-19 has attracted global attention. Early diagnosis and isolation are effective and imperative strategies for epidemic prevention and control. Most diagnostic methods for the COVID-19 is based on nucleic acid testing (NAT), which is expensive and time-consuming. To build an efficient and valid alternative of NAT, this article investigates the feasibility of employing computed tomography images of lungs as the diagnostic signals. Unlike normal lungs, parts of the lungs infected with the COVID-19 developed lesions, ground-glass opacity, and bronchiectasis became apparent. Through a public dataset, in this article, we propose an advanced residual learning diagnosis detection (RLDD) scheme for the COVID-19 technique, which is designed to distinguish positive COVID-19 cases from heterogeneous lung images. Besides the advantage of high diagnosis effectiveness, the designed residual-based COVID-19 detection network can efficiently extract the lung features through small COVID-19 samples, which removes the pretraining requirement on other medical datasets. In the test set, we achieve an accuracy of 91.33%, a precision of 91.30%, and a recall of 90%. For the batch of 150 samples, the assessment time is only 4.7 s. Therefore, RLDD can be integrated into the application programming interface and embedded into the medical instrument to improve the detection efficiency of COVID-19.